Iol Chemicals & Pharmaceuticals Ltd. (BSE: 524164) is a Ludhiana, Punjab-based company in the Medicinal Chemicals and Botanical Products industry. With a market capitalisation of ₹5,719 Cr, it ranks #796 by market cap among the 6,137 Indian listed companies on FinBizNet, and #25 of 86 in Medicinal Chemicals and Botanical Products. At ₹164.14 (as of 25 Oct 2026), the share price is 26.7% below its 52-week high of ₹224.00 and 144.3% above its 52-week low of ₹67.19. The share price is up 67.4% over one year and up 10.0% over three months.
| Current Price | ₹164.14 |
|---|---|
| Market Cap | ₹5,719 Cr |
| BSE Code | 524164 |
| Sector | Health Care > Pharmaceuticals, Biotechnology and Life Sciences > Pharmaceuticals |
| Sub-Industry | Biotechnology and Life Sciences > Medicinal Chemicals and Botanical Products |
| P/E Ratio | 39 |
| Return on Equity | 7.90% |
| Return on Assets | 4.77% |
| 52-Week Range | ₹67.19 – ₹224.00 |
| 1-Year Price Change | +67.4% |
| 3-Month Price Change | +10.0% |
| Beta (1Y) | 0.17 |
| Dividend Yield | 0.55% |
| Headquarters | Ludhiana, Punjab |
| Website | www.iolcp.com |
| Revenue | ₹756 Cr |
|---|---|
| Net Profit | ₹64 Cr |
| Net Margin | 8.5% |
| EPS (Basic) | ₹2.20 |
| Basis | consolidated |
Figures in ₹ crore, parsed from the company's exchange filing (XBRL).
IOL Chemicals and Pharmaceuticals Limited manufactures and sells pharmaceutical and chemical products in India and internationally. The company operates through, Chemical and Pharmaceutical segments. The Chemical segment offers ethyl acetate, iso butyl benzene, acetyl chloride, mono chloro acetic acid, and acetic anhydride to food processing, flexible packaging, pharmaceuticals, textiles, ink, paint, pesticides, and chemical intermediates industries. The Pharmaceutical segment provides active pharmaceutical ingredients, such as ibuprofen, metformin, fenofibrate, lamotrigine, clopidogrel bisulphate, pantoprazole sodium, ursodeoxycholic acid, losartan potassium, gabapentin, levetiracetam, and paracetamol. Its active pharmaceutical ingredients are used for the treatment of anti-inflammatory, analgesic and antipyretic, anti-diabetic, anti- platelet, anti-cholesterol, anti- convulsant, anti-epileptic, anti-hypertensive, and anti-cholelithic, as well as proton pump inhibitor. IOL Chemicals a
1. Chemical-This segment produces and sells ethyl acetate, iso butyl benzene, acetyl chloride, mono chloro acetic acid, para amino phenol, etc. 2. Pharmaceutical-This segment produces and sells various active pharmaceutical ingredients, such as ibuprofen, metformin, fenofibrate, lamotrigine, clopidogrel bisulphate, pantoprazole, ursodeoxycholic acid, gabapentin, levetiracetam, paracetamol, etc. 3. Unallocable-0 4. Inter Segment Revenue-0
1. Pharmaceutical-59.7% 2. Chemical-49.6% 3. Unallocated-0.9%
| Company | Market Cap | P/E | ROE | Latest Qtr Revenue | 1Y Change |
|---|---|---|---|---|---|
| Sun Pharmaceutical Industries Limited | ₹4,21,995 Cr | 36.4 | 14.72% | ₹15,300 Cr | +5.4% |
| Zydus Lifesciences Ltd | ₹1,12,020 Cr | 22.2 | 18.32% | ₹8,017 Cr | +14.7% |
| Laurus Labs Ltd | ₹1,11,310 Cr | 125.3 | 17.74% | ₹2,026 Cr | +125.7% |
| Cipla Limited | ₹1,07,048 Cr | 27.6 | 11.74% | ₹7,119 Cr | -14.7% |
| Dr.Reddys Lab | ₹1,02,611 Cr | 24.1 | 11.52% | ₹8,698 Cr | -0.9% |
| Aurobindo Pharma Ltd. | ₹95,910 Cr | 26.8 | 9.93% | ₹9,150 Cr | +41.7% |
| Mankind Pharma | ₹93,977 Cr | 48.7 | 12.45% | ₹4,031 Cr | -9.9% |
| Lupin Ltd | ₹89,426 Cr | 16.6 | 26.91% | ₹8,277 Cr | -1.1% |
| Iol Chemicals & Pharmaceuticals Ltd. | ₹5,719 Cr | 39 | 7.90% | ₹756 Cr | +67.4% |
Listed by market capitalisation. Ratios are shown for context only.
Iol Chemicals & Pharmaceuticals Ltd. is trading at ₹164.14, with a market capitalisation of ₹5,719 Cr.
Iol Chemicals & Pharmaceuticals Ltd. operates in the Health Care > Pharmaceuticals, Biotechnology and Life Sciences > Pharmaceuticals space (Biotechnology and Life Sciences > Medicinal Chemicals and Botanical Products).
Iol Chemicals & Pharmaceuticals Ltd. has a P/E of 39 and a return on equity of 7.90%.
Iol Chemicals & Pharmaceuticals Ltd. is listed on the BSE under the scrip code 524164.
Iol Chemicals & Pharmaceuticals Ltd.'s share price is up 67.4% over one year and up 10.0% over three months. Its 52-week range is ₹67.19 to ₹224.00.
In Q1 FY27, Iol Chemicals & Pharmaceuticals Ltd. reported revenue of ₹756 Cr and net profit of ₹64 Cr, with basic EPS of ₹2.2 (consolidated, parsed from the company's exchange filing).
Data as of 25 Oct 2026. Descriptive market data only — not investment advice.